Frequently Asked Questions
North America is the dominating region of the Immune-Mediated Inflammatory Diseases Market.
The Immune-Mediated Inflammatory Diseases Market size will be worth 6.50% by 2029
High Prevalence of Arthritis and Rising Healthcare Expenditure are the growth drivers of the Immune-Mediated Inflammatory Diseases Market.
The indication, treatment type, route of administration, end-user and distribution channel are the factors on which the Immune-Mediated Inflammatory Diseases Market research is based.
The major companies in the Immune-Mediated Inflammatory Diseases Market are Pfizer Inc. (U.S.), Abbvie Inc. (U.S.), Novartis AG (Switzerland), Amgen Inc. (U.S.), Boehringer Ingelheim International GmbH. (Germany), Merck & Co Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceuticals Industries Ltd. (Israel), AstraZeneca (U.K.), Ampio Pharmaceuticals Inc. (U.S.), Lilly (U.S.), Zydus Group (India), Akorn, Incorporated (U.S.), DAIICHI SANKYO COMPANY, LIMITED (Japan).
